ONVO Organovo Holdings Inc

Price (delayed)

$7.13

Market cap

$62.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.32

Enterprise value

$25.95M

Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's ...

Highlights
The EPS has increased by 4.9% since the previous quarter and by 3.3% year-on-year
The equity has soared by 51% year-on-year but it has declined by 4.8% since the previous quarter
ONVO's quick ratio is down by 28% from the previous quarter but it is up by 26% YoY
ONVO's gross profit has dropped by 100% year-on-year
The revenue has plunged by 100% YoY

Key stats

What are the main financial stats of ONVO
Market
Shares outstanding
8.71M
Market cap
$62.07M
Enterprise value
$25.95M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.66
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$16.59M
EBITDA
-$16.53M
Free cash flow
-$12.76M
Per share
EPS
-$2.32
Free cash flow per share
-$1.47
Book value per share
$4.29
Revenue per share
$0
TBVPS
$4.4
Balance sheet
Total assets
$38.29M
Total liabilities
$964,000
Debt
$0
Equity
$37.33M
Working capital
$35.69M
Liquidity
Debt to equity
0
Current ratio
38.03
Quick ratio
37.47
Net debt/EBITDA
2.19
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-55.1%
Return on equity
-56.6%
Return on invested capital
-939%
Return on capital employed
-44.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ONVO stock price

How has the Organovo Holdings stock price performed over time
Intraday
1.42%
1 week
2.44%
1 month
-5.94%
1 year
11.58%
YTD
-42.03%
QTD
-24.15%

Financial performance

How have Organovo Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.6M
Net income
-$16.59M
Gross margin
N/A
Net margin
N/A
ONVO's gross profit has dropped by 100% year-on-year
The revenue has plunged by 100% YoY
The net income has declined by 9% year-on-year
The operating income has grown by 6% YoY

Growth

What is Organovo Holdings's growth rate over time

Valuation

What is Organovo Holdings stock price valuation
P/E
N/A
P/B
1.66
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 4.9% since the previous quarter and by 3.3% year-on-year
The equity has soared by 51% year-on-year but it has declined by 4.8% since the previous quarter
The stock's price to book (P/B) is 50% less than its 5-year quarterly average of 3.3 and 36% less than its last 4 quarters average of 2.6
The revenue has plunged by 100% YoY

Efficiency

How efficient is Organovo Holdings business performance
ONVO's return on invested capital is up by 18% since the previous quarter
The ROE has grown by 12% from the previous quarter but it has contracted by 4% YoY
ONVO's return on assets is down by 12% year-on-year but it is up by 12% since the previous quarter

Dividends

What is ONVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ONVO.

Financial health

How did Organovo Holdings financials performed over time
The total assets has increased by 49% year-on-year but it has declined by 4.1% since the previous quarter
The total liabilities is up by 34% since the previous quarter and by 15% year-on-year
ONVO's debt is 100% smaller than its equity
The equity has soared by 51% year-on-year but it has declined by 4.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.